Johns Hopkins University’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Johns Hopkins University’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,077	Closed	-$439K	–	12
2021 Q2	$439K	Hold	1,077	–	–	0.05%	9
2021 Q1	$514K	Buy	+1,077	New	+$586K	0.4%	6

Other funds holding NEXI

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Johns Hopkins University's NEXI Position: Q3 2021 in Review

Johns Hopkins University sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2021, closing a stake of 1,077 shares — an estimated $439K sold.

Johns Hopkins University first reported a position in NEXI in Q1 2021 and held it in 2 quarters. The position peaked at $514K in Q1 2021. 47 funds tracked by Wall St. Rank hold NEXI as of Q3 2021.

Johns Hopkins University reported no remaining NexImmune, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Johns Hopkins University sold 1,077 NexImmune, Inc. Common Stock shares in Q3 2021, an estimated $439K.
Johns Hopkins University first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Johns Hopkins University's NexImmune, Inc. Common Stock position peaked at $514K in Q1 2021.
47 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2021.

Based on Johns Hopkins University's 13F filing for Q3 2021, filed 12 Nov 2021.